4
Changes in Ownership
Kiniksa Pharmaceuticals International, plc Filed Acc 0001415889-25-023874
CHIEF CORP. & COMM. OFFICER sold 3,523 shares at $35.31 ($124,397)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Moat Ross CHIEF CORP. & COMM. OFFICER | 2025-09-04 | Sale 10b5-1 | −3,523 | $35.31 | $124,397 | 9,415 | D |
| Open-market sales · 3,523 sh · avg $35.31 · $124,397 | |||||||
Loading xslF345X05/form4-09082025_080945.xml…